You just read:

Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment

News provided by

Samsung Biologics; Vir Biotechnology

Apr 09, 2020, 23:39 ET